PharmaCyte Biotech, Inc. (PMCB)
0.4865
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.49
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech Price : 0.4865 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 0.50 | 0.5009 | 0.4855 | 0.4865 | 45369.00 |
| Sep 03, 2026 | 0.4896 | 0.5149 | 0.4801 | 0.4913 | 137096.0 |
| Sep 02, 2026 | 0.485 | 0.4986 | 0.4702 | 0.4807 | 48263.00 |
| Sep 01, 2026 | 0.49 | 0.509 | 0.4801 | 0.4881 | 55145.00 |
| Aug 31, 2026 | 0.52 | 0.5298 | 0.48 | 0.5009 | 105515.0 |
| Aug 28, 2026 | 0.5326 | 0.5326 | 0.5044 | 0.515 | 83340.00 |
| Aug 27, 2026 | 0.5503 | 0.565 | 0.531 | 0.5402 | 57215.00 |
| Aug 26, 2026 | 0.548 | 0.551 | 0.5201 | 0.5405 | 73781.00 |
| Aug 25, 2026 | 0.52 | 0.5399 | 0.511 | 0.5396 | 68400.00 |
| Aug 24, 2026 | 0.533 | 0.5399 | 0.52 | 0.525 | 61993.00 |
| Aug 21, 2026 | 0.5180 | 0.5399 | 0.5155 | 0.533 | 92788.00 |
| Aug 20, 2026 | 0.5308 | 0.5324 | 0.5044 | 0.5143 | 92817.00 |
| Aug 19, 2026 | 0.5320 | 0.5398 | 0.5101 | 0.5324 | 54829.00 |
| Aug 18, 2026 | 0.5259 | 0.54 | 0.5043 | 0.5241 | 225946.0 |
| Aug 17, 2026 | 0.557 | 0.557 | 0.5221 | 0.5422 | 104775.0 |
| Aug 14, 2026 | 0.56 | 0.5712 | 0.54 | 0.551 | 132379.0 |
| Aug 13, 2026 | 0.5440 | 0.57 | 0.5440 | 0.55 | 50397.00 |
| Aug 12, 2026 | 0.539 | 0.5826 | 0.53 | 0.5474 | 52809.00 |
| Aug 11, 2026 | 0.546 | 0.58 | 0.54 | 0.55 | 66506.00 |
| Aug 10, 2026 | 0.5901 | 0.60 | 0.545 | 0.546 | 202634.0 |
| Aug 07, 2026 | 0.5848 | 0.60 | 0.5703 | 0.5901 | 63593.00 |
| Aug 06, 2026 | 0.5901 | 0.6108 | 0.5801 | 0.5901 | 30044.00 |
| Aug 05, 2026 | 0.6095 | 0.61 | 0.58 | 0.59 | 22346.00 |
| Aug 04, 2026 | 0.5758 | 0.6108 | 0.5680 | 0.601 | 257451.0 |
| Aug 03, 2026 | 0.5758 | 0.5881 | 0.551 | 0.5758 | 131684.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 8.24 |
| Amgen, Inc. | 437.23 |
| Anika Therapeutics, Inc. | 20.81 |
| BioCryst Pharmaceuticals, Inc. | 9.96 |
| Imunon, Inc. | 1.58 |
Price Related Metrics
| Price to Book Value | 0.1569 |
| Earnings Yield | -635.3% |
| Market Cap | 5.223M |